Interestingly, in several cancers, including breast and ovarian carcinomas, genetic tumor profiling has revealed both FAK DNA amplification (PTK2 gene at 8q24.3) and elevated FAK mRNA levels [19]. This evidence concerns the gene PTK2 and ovarian carcinoma.